From http://www.mbaonline.com/the-rise-of-women-in-tech/:
It’s time for the old adage that women neither like nor do well in math and science be put to rest …
Women are increasingly involved in the tech field, both as consumers
and as practitioners, which shouldn’t come as a surprise since over half
of social media users are women and the average social gamer is a woman
in her 40s.
This trend is also reflected in education. Of the computer science majors graduating in 2013 from Harvard, women make up 41%. And although only 25% of science, tech, engineering and math (STEM) jobs are currently held by women, the numbers are beginning
to shift. Between January of 2011 and 2012, the number of women in the
IT field jumped by more than 28%.
The benefits for women who enter tech are hard to deny. They
experience smaller wage gaps due to gender than women in other
industries. But the relationship between women and tech companies isn’t
one-sided – the companies get some nice perks, too. Companies whose
boards of directors contain 3 or more female members had higher returns
on sales, returns on investments and returns on equity.
The infographic below delves deeper into how the phenomenon of women in tech is on the rise.
Click here to see the graphic!
Showing posts with label translational science. Show all posts
Showing posts with label translational science. Show all posts
Tuesday, October 2, 2012
Sunday, May 6, 2012
Public Affairs Announcements May7th2012
NIH Director Dr. Francis Collins admits, ‘it’s
a scary time to be a young investigator’
On March 28th, the
Senate Labor, Health and Human Services (LHHS) Appropriations Subcommittee held
a hearing on the fiscal year (FY) 2013 funding request for the National
Institutes of Health (NIH). During multiple rounds of questioning following Dr.
Collins’ testimony,
Senator Jerry Moran (R-KS) noted that flat funding for NIH is especially
troubling because “it sends a message to the next generation, the potential
researchers, scientists, and physicians, that the certainty of their career
path or the value of what they do is not recognized.” Dr. Collins responded
that, “It is indeed a scary time for new investigators because they have seen
the likelihood of receiving funding decrease from 25-35 percent to a grim 17
percent.” To read more, see below.
Scary to be a young
investigator: http://www.faseb.org/Policy-and-Government-Affairs/Publications/Washington-Update-Viewer/tabid/1050/ArticleId/790/SENATORS-EXPRESS-CONCERN-ABOUT-PROPOSAL-TO-FLAT-FUND-NIH-IN-FY-2013.aspx
Increasing Translational Science Opportunities
“Basic scientists play a key
role in improving human health and treating disease,” said Richard A.
Galbraith, MD, PhD, Chair of the FASEB committee that organized the meeting and
developed the report and Associate Dean of Patient Oriented Research at the University
of Vermont College of Medicine. “Yet, despite widespread national interest in
accelerating the pace at which medical interventions are developed, few
initiatives have focused specifically on engaging basic investigators in this
process of translation,” Dr. Galbraith added. To read more, see below.
The National Institutes of
Health (NIH) today announced a new plan for boosting drug development: It has
reached a deal with three major pharmaceutical companies to share abandoned
experimental drugs with academic researchers so they can look for new uses. NIH
is putting up $20 million for grants to study the drugs. To read more, see the
link below.
Recycling
old drugs: http://news.sciencemag.org/scienceinsider/2012/05/nih-companies-team-up-to-give.html#more
The U.S. National Academy of Sciences
(NAS) is regarded as the most prestigious honorary scientific society in the
country. But it also has a reputation for being old, white, and male. Today its
members took a big step toward changing their image by inviting a younger and
more diverse group of scientists to join them. To read more, see the link
below.
Recycling old drugs: http://news.sciencemag.org/scienceinsider/2012/05/us-national-academy-gives-itself.html#more
Subscribe to:
Posts (Atom)